why choose us

First received: October 19, 2022

Clinical Trial: The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-Alcoholic Fatty Liver Disease

Study Type: OBSERVATIONAL


Official Title: A Care Path for the Detection of Advanced NAFLD-fibrosis: the Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study - the NLA2 Study

Brief Summary: Non-alcoholic fatty liver disease (NAFLD) is a liver disease, caused by storage of fat in the liver.The most-important risk-factors are being overweight, and disorders in sugar and cholesterol handling of the body.On average does around 30% of the population worldwide have any signs of fatty liver.Most people will not get severe complaints as a result of their fatty liver.But in some of them, the fat storage will lead to hepatitis.This causes damage to the liver which can eventually lead to scarring of the liver,…

Read more